SCHEMBL5705272

SCHEMBL5705272

COC(=O)c1ccc(Cc2cc3c(cc2C)[Si](C)(C)CC[Si]3(C)C)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.56
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 4/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALOX12 P18054 2/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
POLB P06746 1/20 0.45
ALOX15 P16050 1/20 0.45
RECQL P46063 1/20 0.45
ESR2 Q92731 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GNRHR P30968 7/20 0.44
FPR1 P21462 1/20 0.44
GPR183 P32249 1/20 0.44
GPR119 Q8TDV5 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5265419 0.93 HTT (0.56) HTTRAB9ANPC1ALDH1A1NPSR1
SCHEMBL5705545 0.86 GNRHR (0.46) RAB9ANPC1ALDH1A1GNRHRSMN1; SMN2
SCHEMBL5705276 0.81 GNRHR (0.71) ALDH1A1MAPTKDM4EPOLBGNRHR
SCHEMBL14508366 0.79 GNRHR (0.43) GNRHRFPR1GPR183GPR119
SCHEMBL5834348 0.79 GNRHR (0.68) GNRHRFPR1GPR183GPR119
SCHEMBL5264734 0.75 GNRHR (0.59) ALDH1A1MAPTHSD17B10POLBGNRHR
SCHEMBL5266205 0.74 GNRHR (0.71) ALDH1A1MAPTKDM4EPOLBGNRHR
SCHEMBL12018996 0.74 HTT (1.00) HTTRAB9ANPC1ALDH1A1NPSR1
SCHEMBL5266033 0.73 GNRHR (0.53) ALDH1A1GNRHRFPR1GPR183GPR119
SCHEMBL5267626 0.73 GNRHR (0.56) ALDH1A1MAPTHSD17B10POLBGNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562611-B1 HETEROCYCLIC SILICON COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH GNRH (GONADOTROPIN-RELEASING HORMONE) PARADIGM THERAPEUTICS LTD (GB) 2006-08-02 EP disclosed